Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

179
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
179
Crossover Experiments01:16

Crossover Experiments

4.5K
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
4.5K
Cochran's Q Test01:17

Cochran's Q Test

955
Cochran's Q Test is a nonparametric statistical test used to determine if there are potential differences in the outcomes of three or more related groups on a binary (yes/no) or dichotomous outcome. It is essentially an extension of the McNemar Test, which is limited to two related samples - Cochran's Q test can handle three or more related samples, making it more versatile in scenarios where subjects are measured under multiple conditions. The test statistic follows a Chi-Square...
955
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

553
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
553
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

406
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
406
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

194
Body:The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
194

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Beyond the Examination-Does ABIM Longitudinal Knowledge Assessment Performance Reflect Higher-Value Practice?

JAMA internal medicine·2026
Same author

Patient Engagement With Open Notes Following the 21st Century Cures Act.

JAMA health forum·2026
Same author

Health Equity: JAMA Internal Medicine Call for Papers.

JAMA internal medicine·2026
Same author

The Delivery Disconnect: Why We Could Not Model the Impact of Foreign Aid Reductions on Vertical HIV Transmission and What Remains Evident About Strategic Priorities.

Journal of the International AIDS Society·2026
Same author

Identifying and Categorizing Diagnostic Errors in Abdominal Imaging Using a Diagnostic Imaging-Specific Annotation Process.

Journal of the American College of Radiology : JACR·2026
Same author

Response to: 'Methodological concerns on prostate-specific membrane antigen (PSMA) immunohistochemistry for predicting PSMA-PET avidity'.

BJU international·2026

相关实验视频

Updated: Jan 15, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K

卫生政策和实践中的差异差异:对现代方法的审查.

Shuo Feng1, Ishani Ganguli2, Youjin Lee1

  • 1Department of Biostatistics, Brown University School of Public Health, Providence, Rhode Island, USA.

Statistics in medicine
|October 7, 2025
PubMed
概括

本综述综合了健康政策差异因果推理 (DiD) 的最佳实践和创新. 它提供了评估假设,调整共变量,处理分阶时间和强大的推断的指导.

更多相关视频

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

相关实验视频

Last Updated: Jan 15, 2026

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
06:55

Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index

Published on: January 8, 2020

15.0K
The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time
06:05

The Participant-Reported Implementation Update and Score PRIUS: A Novel Method for Capturing Implementation-Related Data Over Time

Published on: February 19, 2021

1.6K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.1K

科学领域:

  • 卫生政策研究 卫生政策研究
  • 观测的因果推理 观察的因果推理
  • 医学中的计量经济学

背景情况:

  • 差异差异 (DiD) 是评估卫生政策和计划的一个关键方法.
  • DiD的有效性取决于平行趋势假设.
  • 最近的进展需要更新DiD在健康应用的最佳实践.

研究的目的:

  • 审查和综合最佳实践和最近在健康政策和医学的DiD方法的创新.
  • 为实施DiD.D.的研究人员提供实用建议.
  • 为了解决传统的DD分析中的挑战和常见陷.

主要方法:

  • 针对医学DID研究的集中文献综述.
  • 综合最佳实践和最近的方法进步.
  • 将建议分为四个关键领域:假设评估,共变量调整,分阶段治疗时间和可靠的推断.

主要成果:

  • 确定了在评估DiD的因果假设时面临的关键挑战.
  • 为调整共变量以放松因果假设的推方法.
  • 突出了在DiD.中考虑分阶段治疗时间的策略.
  • 在标准错误不合适的情况下,提供了关于强大的推理技术的指导.

结论:

  • 采用推实践可以提高健康政策中DiD研究的严格性.
  • 解决方法细微差别对于观察性健康研究中准确的因果推断至关重要.
  • 本次审查支持在健康研究中有效实施先进的DiD方法.